Keywords: Diagnosis/Prediction, Breast
Motivation: Her2-low breast cancers could benefit from new anti-HER2 therapies.
Goal(s): To construct a preoperative prediction model of HER2 expression levels using multiparametric MRI and machine learning (ML) algorithms.
Approach: 621 patients were investigated. Four ML methods were used to build models based on MRI features to predict HER2 expression levels.
Results: MRI features of multiple lesions, spiculated margin, peritumoral edema and largest diameter were selected to build the models. ML models performed better for predicting HER2-zero vs. HER2-low/-overexpression than HER2-low vs. HER2-overexpression. The best model was KNN of AUC 0.86, sensitivity of 76%, specificity of 73%, and accuracy of 75%.
Impact: MRI features of breast cancer are associated with different HER2 expression levels. MRI-based ML models have the potential to preoperatively predict the HER2 expression status.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords